Improving Drug Safety Through Structured Risk Monitoring
Modern healthcare relies heavily on pharmaceutical research to develop safe and effective treatments for a wide range of medical conditions. While medications undergo extensive testing before reaching the market, ongoing monitoring is essential to ensure that potential risks are properly identified and managed. Regulatory agencies and research organizations therefore implement structured programs designed to track medication safety and patient outcomes. One such framework involves Risk Evaluation and Mitigation Strategies Studies, which focus on assessing potential drug-related risks and ensuring that appropriate safety measures are in place.
